Evidence map›Paper›PMID 24979613›Full record

ArticlePloS one2014

SGA children with moderate catch-up growth are showing the impaired insulin secretion at the age of 4.

Ivana Milovanovic, Falucar Njuieyon, Samia Deghmoun, Didier Chevenne, Claire Levy-Marchal, Jacques Beltrand

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ivana MilovanovicINSERM CIE 05 - Unité d'épidémiologie clinique, Hôpital Robert Debré, Paris, France.
Falucar NjuieyonINSERM CIE 05 - Unité d'épidémiologie clinique, Hôpital Robert Debré, Paris, France.
Samia DeghmounINSERM CIE 05 - Unité d'épidémiologie clinique, Hôpital Robert Debré, Paris, France.
Didier ChevenneService de biochimie et hormonologie, Hôpital Robert Debré, Paris, France.
Claire Levy-MarchalINSERM CIE 05 - Unité d'épidémiologie clinique, Hôpital Robert Debré, Paris, France.
Jacques BeltrandEndocrinologie et diabétologie pédiatrique, Hôpital Necker, Paris, France; Université Paris 5, René Descartes, Paris, France; INSERM U845, Imagine Affiliated, Paris, France.
Inserm · FRHôpital Robert-Debré · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBeing born small for gestational age (SGA) is a risk factor for later development of type 2 diabetes. The development of glucose tolerance disorders in adults involves insulin resistance and impaired insulin secretion.

objectiveTo evaluate insulin secretion and insulin sensitivity in a 4-yr old cohort of SGA.

methods85 children were prospectively followed from mid-gestation to 4 years of age. Fetal growth velocity (FGV) was measured using ultrasound measurements. Body composition and hormonal profile were measured at birth, 1 and 4 years.

results23 SGA babies had lower birth weight compared to 62 AGA (-1.9±0.3 vs. -0.6±0.8 z-score; p<0.0001) and they were thinner at birth (ponderal index 24.8±1.8 vs. 26.3±3.1 kg/m3; p = 0.01 and fat mass 11±2.6 vs. 12.9±3.1%; p = 0.01). No significant differences in other measured metabolic and hormonal parameters were observed between two groups at birth. SGA infants experienced an early catch-up growth in weight (mean gain of 1.1±0.6 SD) during the first year of life. At 4 years, SGA children remain lighter than AGA, but with weight z-score in the normal range (-0.1±1.3 vs. 0.5±1.3 z-score; p = 0.05). No excess of fat mass was observed (19±4.8 vs. 19.7±4.1%; p = 0.45). 120-min plasma glucose was significantly higher (6.2±1.1 vs. 5.6±0.9 mmol/l; p = 0.006) and insulinogenic index was significantly lower (0.28±0.15 vs. 0.40±2.4; p = 0.02) in the SGA group at 4-yrs of life contrasting with a preserved insulin sensitivity (QUICKI 0.47±0.09 vs. 0.43±0.05; p = 0.06).

conclusionSGA children with compensatory catch-up growth in first year of life show mild disturbances of glucose tolerance associated to a lower insulinogenic index at 4-yrs of age suggesting impairment of β-cell function.

Indexed as

Infant, Small for Gestational AgeInsulin ResistanceAdultBlood GlucoseBody HeightBody Mass IndexBody WeightChild, PreschoolFemaleGlucose Tolerance TestHumansInfant, Low Birth WeightInfant, NewbornInsulinInsulin-Secreting CellsInsulin SecretionBlood GlucoseInsulin

Identifiers

PMID24979613
PMCPMC4076235
OpenAlexW2012579549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.